Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can School-Based therapy help kids with autism and intellectual disability?

NCT ID NCT07326267

Symptom relief Sponsor: Çankırı Karatekin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new occupational therapy program in schools for children aged 6 to 14 with Autism Spectrum Disorder or Intellectual Disability. The program focuses on improving sensory processing and daily living skills through weekly 50-minute sessions over 10 to 12 weeks. Researchers will compare the therapy group to a control group receiving family education and a home program. The goal is to see if this school-based approach helps children achieve personal goals and function better in everyday activities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Regular school attendance (Anticipated ability to attend at least 70% of the planned intervention sessions during the study period); * Written informed consent obtained from the family; * Formal diagnosis of Autism Spectrum Disorder or Intellectual Disability, documented by an official disability report; * Presence of observable difficulties in sensory processing and activities of daily living (ADL), verified through the student's Individualized Education Program (IEP) records; * Ability to partially follow single-step basic instructions, as documented in the IEP records; * Willingness of families and teachers to participate in follow-up assessments (T2 and beyond). Exclusion Criteria: * Uncontrolled epilepsy or other medical conditions that may interfere with participation or safety during sessions. * Medical contraindications to modalities such as swinging or deep pressure or severe musculoskeletal limitations preventing participation in task-oriented ADL practice. * Being in a period of severe acute behavioral crisis; * Concurrent participation in occupational therapy or special education programs for ≥2 hours per week that would compromise data interpretation; * Presence of severe visual or hearing impairments that would substantially limit the child's ability to perceive sensory stimuli, follow task instructions, or validly engage in assessment procedures; * Inability to maintain family and/or teacher collaboration throughout the intervention period; * Inconsistent school attendance during the intervention period (e.g., prolonged absenteeism); * Insufficient language comprehension to engage with basic task instructions even with support.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder (ASD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder intellectual disability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder (ASD) Intellectual disability, variable

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.